Programme
6th Annual WVI Symposium
Main Program 2008
Thursday, May29th 2008
12.30 SESSION I: Bioengineering: The latest Innovations in Vascular Disease
Moderators: Prof Dusan Pavcnik MD M PhD, Prof David L Gillespie, MD
13.57 SESSION II: Carotid Disease I: Endovascular Management. Lessons from the past we can bring to the future.
Moderators: Prof Piegiorgio Cao MD FRCS, Dr Rodney A. White MD.
15.08 SESSION III: Peripheral Vascular Disease I: The Current status of Endovascular Management. Is it now the gold standard?
Moderators: Sir Peter R. F. Bell MD FRCS DSC KBE, Dr Anil P Hingorani MD
16.10-16.30 COFFEE BREAK
16.30 SESSION VI: Vascular Training: How to train the Endovascular Specialist of the future: International Perspectives
Moderators: Prof K Craig Kent MD, Prof John P Fletcher MD MS FACS FRCS DDU
17.36 SESSION VII: The Future of Vascular Surgery
Moderators: Prof Frank J Veith MD, Prof Jerry Goldstone MD FACS FRCS E, Prof James C Stanley MD
18.13 Honorary Address and Life Achievement award Vascular Surgery: My Vision for the Future
AWARD Presented to Sir Peter R F Bell MD FRCS DSC KBE by Prof Frank J Veith MD
Friday, May30th 2008
7.00 Breakfast Symposium
8.00 SESSION VIII: Vascular Screening and Imaging Techniques. The benefits of early detection and the latest imaging modalities for optimal management.
Moderators: Dr Mark Davies MD FACS PHD, Prof Dieter Raithel MD PhD
8.38 SESSION IX: Contemporary Management of Thoracoabdominal Aortic Aneurysms. Can Endovascular Technology give Sustainable Results?
Moderators: Dr Jacob Buth MD, Dr Rodney A White MD
9.53 SESSION X: Thoracic Aortic Disease: Aneurysm, Dissection and Coarctation: From Hybrid Techniques to Best Medical Management
Moderators: Prof Frank J Veith MD, Mr Sherif Sultan MD FRCS EBQS-Vasc
10.38-10.55 COFFEE BREAK
10.55 SESSION XI: Carotid Disease II: When to operate and the influence of plaque morphology and Statin therapy.
Moderators: Mr Colin Bicknell MRCS, Prof Georgio M Biasi MD
11.59 SESSION XII: Abdominal Aorta: Pushing the boundaries. Hybrid techniques and High Risk Patients.
Moderators: Dr Jacob Buth MD, Dr Mark Eskandari MD 13.35-14.30: LUNCH
14.30 SESSION XIII: Peripheral Vascular Disease II: Medical Optimisation and Adjuvant Techniques
Moderators: Sir Peter R F Bell MD FRCS DSC KBE, Prof Dimitri P Mikhalidis MSc MD FACB FFPM FRCP FRCPath.
15.11 SESSION XIV: The Diabetic Foot and Wound Management: Are we prepared for the Diabetes Epidemic?
Moderators: Dr Sean Dinneen FRCPI FACP, Prof Cliff P Shearman MS FRCS,
15.54 SESSION XV: Renal and Visceral Disease: Vascular Management and Organs Protection
Moderators: Prof Jerry Goldstone MD FACS FRCS E, Prof James C Stanley MD
16.49-17.00: COFFEE BREAK
17.00 SESSION IV: Venous Disease I: Varicose Veins
Moderators: Mr K Simon Cross MD MMed.Sci. FRCSI(Gen.) FRCS(Ed.), Prof Anthony J Comerota MD FACS FACC
17.48 SESSION V: Venous Disease II: Modern Management Deep Vein Thrombosis
Moderators: Prof Alan Dardick MD PhD, Prof Mark Morach MD
18.19 SESSION XVI: Miscellaneous Topics
Moderators: Prof J Gregory Modrall MD, Prof Piegiorgio Cao MD FRCS
Thursday, May29th 2008
SESSION I: Bioengineering: The latest Innovation in Vascular Disease
Moderators: Prof Dusan Pavcnik MD, Prof David L Gillespie MD
12.30 Helical Bloodflow to Reduce Intimal Hyperplasia
Colin Bicknell
12.37 Regulation of vessel identity during vein graft adaptation
Alan Dardik
12.44 Is it possible to modify atherosclerotic plaque stability: can bone marrow derived cells stabilise the fibrous cap of atherosclerotic plaque?
John P Fletcher, AK Guiffre, MWY Williams, M Vicaretti and H Medbury
12.51 Tissue Engineering of Venous Valves
Dusan Pavcnik
12.58 Tissue engineering of Venous Valves
Michel Perrin
13.05 Advances in Ablation of the greater saphenous vein in the 21st Century: Development of an Endovenous Upward Perforate Invaginate (EUPIN) stripping device and procedure based on best medical practice.
Marto Hoary, Sherif Sultan
13.12 Preclinical Medical Device Testing and the Potential of Non-Invasive Imaging
Caitríona Lally,* Vittoria Flamini, Christian Kerskens, Arthur Creane, Daniel Kelly, Niamh Hynes, Sherif Sultan
13.19 Capturing the value of medical device innovations
Eamon Brady
13.26 Regulatory and Credentialling Issues in the US: Impact of evolution of new technologies
Rodney A White
13.33: Drug-Eluting Stents: Does the status quo make sense?Michael Drues
13.47-13.57 Discussion
SESSION II: Carotid Disease I: Endovascular Management. Lessons from the past we can bring to the future.
Moderators: Prof Piegiorgio Cao MD FRCS, Dr Rodney A White MD.
13.57 What is the Learning Curve with CAS and how can we Short Circuit it?
Piegiorgio Cao
14.04. Endovascular management of patients with concomitant carotid and coronary artery disease
Max .Amor, G. Ethevenot, C.Breton, JPS. Simon, Z. Chati
14.11 Carotid stenting in patients with acute coronary syndrome: Role and technique
Carlos H. Timaran, Eric B. Rosero, J Gregory Modrall, James Valentine, Patrick Clagett,.
14.18 The SPACE And EVA 3S Trials: What Effect Are They Having On Carotid Treatment In Europe?
Colin Bicknell
14.25 Carotid Endarterectomy vs Carotid Stenting in Octogenarians
Anthony J. Comerota,
14.32 Carotid Artery Stenting (CAS) Versus Carotid Endarterectomy (CEA) For Asymptomatic Disease: A Single Center Review
Mark K. Eskandari,
14.39 Carotid Artery Intervention In High-risk Patients: Carotid Artery Stenting (CAS) Under Neuro-protection, Carotid Endarterectomy (CEA) And Best Medical Therapy (BMT) for symptomatic patients with low Grey Scale Median (GSM)
Niamh Hynes, Sherif Sultan
DEBATE
14.44 Carotid Artery Stenting has been firmly established as a treatment for all forms of Carotid Artery Disease.
Piegiorgio Cao
14.51 Carotid Artery Stenting needs a lot of development before it can become routine clinical practice. Endarterectomy remains the gold standard.
Sherif Sultan
14.58 -15.08 Voting & Panel Discussion
SESSION III: Peripheral Vascular Disease I: The Current status of Endovascular Management. Is it now the gold standard?
Moderators: Sir Peter R F Bell MD FRCS DSC KBE, Dr Anil P Hingorani MD
15.08 Subintimal Angioplasty (SIA) vs. Bypass surgery (BS) in TASC C and D lesions in the femoro-popliteal segment. Randomization of CLI Patients according to plaque echolucency. A 5-year prospective study.
Sherif Sultan, Niamh Hynes
15.15 Re-entry Devices: Application and utility.
Anil P Hingorani
15.22 Role of trans-stenotic pressure gradient during endovascular interventions and a simplified technique to measure it
Ali Amin
15.29 Lower extremity revascularization in 1020 cases: lessons learned with duplex arteriography
Anil P Hingorani
15.36 Prevalence and Correlation of Hyperhomocysteinemia to Amputation Free Survival (AFS), Major Adverse Events (MAE) and Mortality after Intervention for Critical Lower Limb Ischaemia (CLI) in Patients with Peripheral Vascular Disease (PVD).
Helen M Heneghan, Sherif Sultan
15.41 Tibial Balloon Angioplasty (TBA) Vs Cool Eximer Laser Assisted Angioplasty (CELA) in Management of Infragenicular Tibial Arterial Occlusion in Critical Lower Limb Ischaemia (CLI): An Observational Parallel Group Comparative Study
Wael Tawfick, H Nashat, Helen Heneghan, Sherif Sultan
DEBATE
15.46 Endovascular treatment is now the gold standard for lower limb revascularisation
Sir Peter R F Bell
15.53 Bypass Surgery will always have a secure place in the management lower limb occlusive disease.
Martin Feeley
16.00-16.10 Voting & Discussion Panel
16.10-16.30 COFFEE BREAK
SESSION VI: Vascular Training: How to train the Endovascular Specialist of the future: International Perspectives
Moderators: Prof K Craig Kent MD, Prof John P Fletcher MD MS FRACS FRCS DDU
16.30 The Influence of Deliberate Practice Volume (DPV) on the Slope of the Learning Curve for Vascular Training in a Tertiary Referral Centre: A Prospective Analysis.
Sherif Sultan, Niamh Hynes
16.37 219 fellows’ perception of the future of vascular surgery
Anil P Hingorani
16.44 Developments in Vascular Surgical Training in the UK
Cliff P Shearman
16.51 Training of Vascular and Endovascular Surgery in the United States
K Craig Kent
16.58 Vascular Training in Europe
Giorgio M Biasi
17.05 Vascular Training in Australia
John P Fletcher
DEBATE: The Future of Vascular Surgery Training
17.12 Combined Cardiac and Vascular Training Pathways
Mark Davies
17.19 Combined Interventional and Radiology Training in the UK
Cliff P Shearman
17.26-17.36 Voting & Panel Discussion
SESSION VII: The Future of Vascular Surgery
Moderators: Prof Frank Veith MD , Prof Jerry Goldstone MD FACS FRCS E, Prof James C Stanley MD
17.36 Patient –Centric versus Specialty-centric Care: The Michigan Experience
James C. Stanley
17.42 Who in Vascular Surgery will have Time for Research Today and in the Future?
K Craig Kent
DEBATE: Vascular Surgery Independence
17.49 We have more in common in Cardiologist, Cardiac Surgeons and interventionalists. Our differences with General Surgery are too great to sustain a meaningful relationship.
Frank Veith
17.56 We must not cut our ties and become extinct before we exist: There is room for self-governance under the watchful eye of general surgery.
Martin Feeley
18.03-18.13: Voting & Panel discussion
Honorary Address and Life Achievement award
18.13 Vascular Surgery: My Vision for the Future
Sir Peter R F Bell MD FRCS DSC KBE
18.25 AWARD Presented by Prof Frank J Veith MD
Friday, May30th 2008
7.00-8.00 BREAKFAST SYMPOSIUM
SESSION VIII: Vascular Screening and Imaging Techniques. The benefits of early detection and the latest imaging modalities for optimal management. Moderators: Dr Mark Davies MD FACS PHD, Prof Dieter Raithel MD PhD
8.00 The Modern Endovascular Suite: The latest imaging modalities for optimal management of Vascular Disease
Mark Davies
8.07 Use of 3D Rotational Angiography in Endovascular Procedures
Max.Amor, G. Ethevenot, C.Breton, JPS. Simon, Z. Chati
8.14 IVUS: A core technology
Rodney A White
8.21 Screening and Abdominal Aortic Aneurysms – An Update
K. Craig Kent
8.28-8.38: Discussion
SESSION IX: Contemporary Management of Thoracoabdominal Aortic Aneurysms. Can Endovascular Technology give Sustainable Results?
Moderators: Dr Jacob Buth MD, Dr Mark Eskandari MD
8.38 Fenestrated endovascular grafts for juxtarenal aortic aneurysms: a step by step technical approach.
Sean O’Neill
8.45 Overt Colonic Ischemia after Endovascular Repair of Thoracoabdominal Aortic Aneurysms with Visceral Revascularization
Carlos H. Timaran, Eric B. Rosero, J Gregory Modrall, James Valentine, PatrickClagett,.
DEBATE: Modern Management of Thoracoabdominal Aortic Aneurysms
8.52 Fenestrated branched endograft or hybrid procedure for suprarenal AAA: Are we there yet?
Jacob Buth
8.59 Hybrid surgical/endovascular repair of thoraco-abdominal aneurysms maybe the current best option
Colin Bicknell
9.06-9.16 Voting & Panel Discussion
9.16 Abdominal Aortic Coarctation: Thoracoabdominal Bypass, Patch Aortoplasty or Aortic Interposition Graft
James C. Stanley
9.23 Paradigm Shift in Open Pararenal Aortic Aneurysm Repair in the Endovascular Era: 5-Years Experience.
Niamh Hynes, Sherif Sultan
9.28 The Role of Prostaglandin I2 Infusion in Elective Open Repair of Abdominal Aortic Aneurysm.
Chris Beirne, Niamh Hynes, Sherif Sultan
9.33 Continuous AutoTransfusion System (C.A.T.S) in Open Abdominal Aortic Aneurysm Repair: 9 Years Experience in a Tertiary University Vascular Center
Wael Tawfick, S Sultan
9.38-9.45: Discussion
SESSION X: Thoracic Aortic Disease: Aneurysm, Dissection and Coarctation: From Hybrid Techniques to Best Medical Management
Moderators: Dr Frank J Veith MD, Mr Sherif Sultan MD FRCS EBQS-Vasc
9.45 Neurologic Complications Associated with Endovascular Repair of Thoracic Aortic Pathology: Incidence and Risk factors. A Study from the EUROSTAR Registry
Jacob Buth
9.52 Hybrid approaches to TAAs involving arch vessels: extra-anatomic bypass is less invasive and best.
Mark Davies, Eric K. Peden, Jon-Cecil Walkes, Michael J. Reardon
9.59 Debranching Techniques in Thoracic Aortic Aneurysms and Dissections
D Raithel, L Qu
10.06 Arch and visceral branch management in association with endovascular repair of thoracic aortic pathology
Mark D. Morasch
10.13 TEVAR for indications beyond TAA, Disections and trauma
Rodney A White
10.20Thoracic Aortic Dissections: Medical Treatment Versus Intervention
Mark K. Eskandari
10.27-10.37: Discussion
10.37-10.50 COFFEE BREAK
SESSION XI: Carotid Disease II: When to operate and the influence of plaque morphology and Statin therapy.
Moderators: Mr Colin Bicknell MRCS, Prof Georgio M Biasi MD
10.50 Carotid Plaque Characteristics and their therapeutic and Prognostic implications
Giorgio M Biasi
10.57 Selection of Carotid plaque for Intervention. Does the global use of Statins impact the number of interventions.
Luis Mendes Pedro
11.04 Carotid stenosis and stroke; innocent until proven guilty.
Tim Counihan, Mudassir Iqbal
11.11 Ocular Findings as Predictors of Carotid Artery Occlusive Disease (CAOD)
J. Gregory Modrall, Patty I. Boyd, G. Patrick Clagett,
11.18 Brain Injury Markers After CEA And CAS: Are There Differences And What Is The Role Of The Circle Of Willis In Predicting Which Patients Should Get Which Treatment?
Colin Bicknell
11.25 Stroke and Lipids
Dimitri P Mikhailidis
11.32 Trends and outcomes of concurrent carotid and coronary revascularization: Effects of carotid stenting vs endarterectomy on coronary bypass
Carlos H. Timaran, Eric B. Rosero, MD, J Gregory Modrall MD, MD, James Valentine, MD, Patrick Clagett, MD.
11.39 Double blinded randomized trial of thin versus ultra-thin Dacron patching in carotid endarterectomy (CEA): short-term technical and clinical outcome
Niamh Hynes, Sherif Sultan
11.44-11.54 Discussion
SESSION XII: Abdominal Aorta: Pushing the boundaries. Hybrid techniques and High Risk Patients.
Moderators: Prof Frank Veith, Mr Sherif Sultan
11.54 Staging the NAIS: Feasibility and short term Outcomes
John Eidt
12.01 A Prospective Clinical, Economic, and Quality-of-Life Analysis Comparing Endovascular Aneurysm Repair (EVAR), Open Repair, and Best Medical Treatment in High-Risk Patients With Abdominal Aortic Aneurysms Suitable for EVAR: The Irish Patient Trial
Sherif Sultan, Niamh Hynes
12.08 Long-term (13yrs) follow-up after Endovascular Aneurysm Repair: is it a durable intervention?
John P Fletcher
12.15 EVAR Should Be the Gold Standard for Treatment of Ruptured AAAs: All Vascular Surgeons Should Be Prepared To Do It And Do It Right
Frank J. Veith
12.22 AUI Endograft (LeMaite Vascular): Phase I Clinical Trial update.
Rodney A White
12.29 Aorto-Uniliac Vs Bifurcated Endovascular Aortic Repair: Technical Success, Secondary Intervention Rate and Quality-adjusted cost analysis.
Sherif Sultan, Niamh Hynes
12.36 Follow-up of patient's following EVAR: “The Good, the Bad and the Ugly"
Ian Davidson
DEBATE 12.43 Small AAAs Do Not Become Less Suitable For EVAR If They Are Observed For Long Periods: We Don’t Need A Small AAA Trial
Franklin S Yau, Eric B Rosero, G Patrick Clagett, R James Valentine, J GregoryModrall, Frank R Arko, Carlos H Timaran
12.50 Comparison of surveillance vs Aortic Endografting for Small Aneurysm Repair (CAESAR) trial: study design and progress
Piegiorgio Cao
12.57-13.07: Voting & Panel Discussion
13.07 EVAR versus Open Repair in Octogenarians
Anthony J. Comerota
13.14 Survival Rate of Octogenarians versus Younger Patients following Abdominal Aortic Aneurysm Repair in a Tertiary Referral Center
Niamh Hynes, Sherif Sultan
13.19 Derivation and Validation of a Customized Risk Scoring Index for Abdominal Aortic Aneurysm Patients.
Chris Beirne, Sherif Sultan
13.24-13.34: Discussion
13.34-14.30: Lunch
SESSION XIII: Peripheral Vascular Disease II: Medical Optimisation and Adjuvant Techniques
Moderators: Prof Peter R F Bell MD FRCS DSC KBE, Prof Dimitri P Mikhalidis MSc MD FACB FRCP FRCPath
14.30 Up-to-Date Management of PAD and Current Guidelines
Anthony J. Comerota
14.37 Statins and peripheral arterial disease
DP Mikhailidis
14.44 Early and Late Venous Morbidity After Harvesting Femoral Vein J.
Gregory Modrall, Jennie Hocking, PA-C, G. Patrick Claget,
14.51 A prospective comparative study of pre-operative Duplex Ultrasound Arterial Mapping (DUAM), Digital-Subtraction Angiography (DSA) and Magnetic Resonance Angiography (MRA) in Critical Lower Limb Ischaemia (CLI) prior to Endovascular Revascularization (EvR).Clinical, Technical and Economic outcome.
Chris Beirne, Sherif Sultan
14.56 Last Ditch Therapy in Unreconstructable Peripheral Arterial Disease in Patients with Critical Limb Ischaemia; A Four Year Experience
Wael Tawfick, Sherif Sultan
15.01-15-11: Discussion
SESSION XIV: The Diabetic Foot and Wound Management: Are we prepared for the Diabetes Epidemic?
Moderators: Dr Sean Dinneen FRCPI FACP, Prof Cliff P Shearman MS FRCS
15.11 How to reduce amputation rates in diabetes
Cliff P Shearman
15.18 Establishing a Diabetic foot service: challenges and opportunities
Sean Dinneen
15.25 V.A.C.® Therapy enhances patients independence and revenue generation
Stella Vig,
15.32 Efficacy of platelet concentrate for wound healing
Arjan J. van den Hil
15.39 Does the Stake of Re-Amputation Justify Initial Trans-metatarsal Foot amputation (ITMA) Over initial Digital Amputation (IDA)? A comparative longitudinal 5 years Logistical study of ITMA Vs IDA for critical limb ischaemia (CLI) post revascularisation.
Gabrielle Colleran, Helen Heneghan, Clare-Anne McKeon, Sherif Sultan.
15.44-15.54 Discussion
SESSION XV: Renal and Visceral Disease: Vascular Management and Organs Protection
Moderators: Prof James C Stanley MD, Prof Jerry Goldstone MD FACS FRCS E
15.54 Is Renal Duplex Scanning Prudent in the Era of CTA and MRA: Experience with over 1000 renal duplex scans
Jerry Goldstone
16.01 Prevention and management of contrast induced nephrotoxicity (CIN)
Donal Reddan
16.08 Endovascular & Adjuvant techniques in preventing Radiocontrast nephropathy
Ali Amin
16.15 Changes in the Practice of Angioaccess Surgery: Impact of Dialysis Outcome and Quality Initiative (DOQI)
Anil P Hingorani
16.22 Hepato-Renal and Spleno-renal bypass: Alternative to aorto-renal reconstruction
Jerry Goldstone
16.29 Management of Median Arcuate Ligament Syndrome (MALS) with decompression and Coeliac Ganglion Sympathectomy (CGS), Case Series and Literature Review.
Brian J Manning, Sherif Sultan.
16.34-16.44: Discussion
16.44-17.00: COFFEE BREAK
SESSION IV: Venous Disease I: Varicose Veins
Moderators: Mr Simon Cross, Prof Anthony J Comerota MD FACS FACC.
17.00 Venous Surgery is not all about Varicose Veins
Mahj S Gohel, Alun H Davies
17.07 Comparison of Endovenous Upward Perforate Invaginate Stripping (EUPIS), Downward Invaginate (DIS) and High-energy Endovenous LASER ablation (HE-EVLA) for Varicose Veins: Factors Influencing Complication Rate, Long-term Recurrence, Quality of Life and Cost-effectiveness.
Niamh Hynes, Sherif Sultan.
17.12 How to Avoid Litigation
Simon Cross,
17.19 Cryptogenic Storke: Should all patents be screened for Patent Foramen Ovale
Brendan O’Cochlain
17.26 Rationale for Venous Surgery in the treatment of Venous Leg Ulcers
Michel. Perrin.
17.33 Early Results of Topical Wound Oxygen (TWO2) Therapy in the Management of Refractory Non-Healing venous Ulcers (RVU); superior Role over Conventional Compression Dressings (CCD)
Wael Tawfick, Sherif Sultan
17.38-17.48 Discussion
SESSION V: Venous Disease II: Modern Management Deep Vein Thrombosis
Moderators: Prof Alan Dardick, Prof Mark Morach
17.48 Superficial thrombophlebitis. Propagation of thrombosis to SPJ and SFJ. When to ligate and when to medicate.
Martin Feeley
17.55 Drawbacks of SVC filters and risk factors for mortality in patients with upper extremity DVT
Anil P Hingorani
18.02 How Long After DVT Should Anticoagulation Be Continued?
Anthony J. Comerota
18.09-18.19 Discussion
SESSION XVI: Miscellaneous Topics
Moderators: Prof J Gregory Modrall MD, Prof Piegiorgio Cao MD FRCS
18.19 Open and Endovascular Management of Vascular Trauma
David L. Gillespie
18.26 The Inflammatory Response to Cardiac Surgery
John G. Laffey
18.33 How Low Should we go when Treating Cholesterol?
DP Mikhailidis.
18.40 Recombinant Actwivated Factor VII (rFIIa) in Critical Vascular Surgery Bleeding: Five Years Experience
Wael Tawfick, M O’Connor, S Tawfik, N Hynes, S Sultan
18.45 Scalenus Anterior Resection assessment by Disability of Arm Shoulder & Hand (DASH) scoring in the management of Thoracic Outlet Syndrome.
Arshad Hussain, Sherif Sultan
18.50 Femoral artery access in arterial reconstructive surgery. How to minimize groin infection: 5 year results
Beirne C, Sultan S
18.55 The Influence of Interpulse Irrigation System, skin adhesive and wound exposure on Surgical Site Infection Rates in a Tertiary Referral Centre
Triona Walsh, Wael Tawfick, Sherif Sultan
19.00 Nasal carriage of Methicillin-Resistant Staphylococcus aurous (MRSA) is not detected among General Public Visiting a Tertiary Hospital.
Elrasheid A H Kheirelseid , Aidan Devitt, Martin Cormican
19.05-19.15: Discussion
19.15 ADJOURN
6th Annual WVI Symposium Wound Care Workshops 2008
Please note that demonstrations will also take place in the above workshops. These demonstrations will run concurrently with the Wound Care talks as well as the Main Sessions
Thursday, May 29th 2008
|
1.00 – 1.15 |
Wael Tawfick | Advances in Management of Arterial & Venous Ulcers |
| 1.20 – 1.35 | Chris Beirne | Current Management of Skin grafts |
| 1.40 – 1.55 | Mary Burke | Principals of Wound Bed Preparation; Tissue, Infection, Moisture, Edge |
| 2.00 – 2.15 | Anna Sheeran | VAC Therapy |
| 2.20 – 2.35 | Marion Cahill-Collins | Exudate Management |
| 2.40 – 2.55 | Laura Kelly | The Diabetic Foot |
Main Hall
15.08 – 16.10: Session III: Peripheral Vascular Disease I: The Current Status of Endovascular Management: Is It Now the Gold Standard?
16.10 – 16.30 Coffee Break
Friday, May 30th 2008
|
09.00 – 09.15 |
Fiona Alexander | Silver Dressing |
| 09.20 – 09.35 | Georgina Gethin | Current evidence for the use of Maluca Honey in Wound Healing |
| 09.40 – 09.55 | Adeline Green | Pressure Ulcers |
| 10.00 – 10.15 Coffee Break | ||
| 10.15– 10.30 | Judith Davitt | Infection Control Issues in Wound Care |
| 10.35 – 10.50 | Chris Beirne | Current Management of Skin Grafts |
| 10.55 – 11.10 | Wael Tawfick | Advances in Management of Arterial & Venous Ulcers |
| 11.15 – 11.30 | ||